While previous studies have linked vitamin D deficiency with obesity….
Read More »Remove Your Stress and Decrease Risk of Diabetes
Men who are permanently stressed are significantly more likely to develop type 2 diabetes than men with no stress in their lives….
Read More »Testosterone and Diabetes, Part 1 of 3
In this week’s Homerun Slides series prepared for by Sara Dempsey, Doctor of Pharmacy Candidate, LECOM, we review some background information on testosterone and why it is important, and the potential causes of low testosterone and its effects….
Read More »Diabetic Emergencies, Diagnosis and Clinical Management: Sick-Day Rules in Diabetes, Part 1
Konstantinos Makrilakis, Nikolaos Katsilambros During an acute illness, blood sugar levels usually rise. Illness causes a greater than normal demand for insulin due to the release of stress hormones such as adrenaline (epinephrine), cortisone, and growth hormone. These hormones can be triggered by any kind of stressful condition such as …
Read More »Use Sticky Ideas to Lose the Weight — and Keep It Off This Time
by Sheri Colberg, PhD This time of year always brings the desire to lose a few pounds (or more) to the forefront of people’s minds. But how do you know how to go about doing it?
Read More »Modified Vial Specifications for Humulin R U-500 (Concentrated)
Modified Vial Specifications for Humulin R U-500 (Concentrated) Eli Lilly and Company has updated the Humulin R U-500 (500 units/mL) vials. These slight modifications will not change the volume (20 mL), storage, label, or packaging of Humulin R U-500. The new vials will have a lower fill level of liquid …
Read More »Calcium Supplements May Increase Risk of CVD Death
A high intake of supplemental calcium appears to be associated with an increased risk of CVD death in men but….
Read More »Next Once-Daily GLP-1 Agonist, Lixisenatide, Approved in EU
One more GLP-1 agonist gets approved in Europe…. The European Commission has granted approval of lixisenatide (Lyxumia, Sanofi) for the treatment of adults with type 2 diabetes. The drug, a once-daily glucagon-like peptide 1 (GLP-1) agonist, is indicated to achieve glycemic control in combination with oral glucose-lowering products and/or basal …
Read More »New England Journal Refutes Weight-Loss Beliefs in New Review
With data from the scientific literature, some of the most firmly held beliefs about weight loss are unproven or downright untrue….
Read More »Mechanism that Links Diabetes and Obesity with Cancer Discovered
Sustained high levels of sugars damage our cells and can….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.